메뉴 건너뛰기




Volumn 105, Issue 1-3, 2008, Pages 138-143

A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment

Author keywords

Antipsychotic medications; Clozapine; Neuropsychology; Ziprazidone

Indexed keywords

ANXIOLYTIC AGENT; CLOZAPINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; ZIPRASIDONE;

EID: 53149118253     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.11.014     Document Type: Article
Times cited : (25)

References (13)
  • 1
    • 0036268294 scopus 로고    scopus 로고
    • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia and schizoaffective disorder
    • Bilder R.M., Goldman R.S., Volavka J., et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia and schizoaffective disorder. Am. J. Psychiatry 159 (2002) 1018-1028
    • (2002) Am. J. Psychiatry , vol.159 , pp. 1018-1028
    • Bilder, R.M.1    Goldman, R.S.2    Volavka, J.3
  • 2
    • 0028149927 scopus 로고
    • The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
    • Buchanan R.W., Holstein C., and Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol. Psychiatry 36 (1994) 717-725
    • (1994) Biol. Psychiatry , vol.36 , pp. 717-725
    • Buchanan, R.W.1    Holstein, C.2    Breier, A.3
  • 4
    • 0035140610 scopus 로고    scopus 로고
    • Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment
    • Harvey P.D., and Keefe R.S.E. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am. J. Psychiatry 158 (2001) 176-184
    • (2001) Am. J. Psychiatry , vol.158 , pp. 176-184
    • Harvey, P.D.1    Keefe, R.S.E.2
  • 5
    • 0034670602 scopus 로고    scopus 로고
    • Practice-related improvement in information processing with Novel antipsychotic treatment
    • Harvey P.D., Moriarty P.J., Serper M.R., Schnur E., and Lieber D. Practice-related improvement in information processing with Novel antipsychotic treatment. Schizophr. Res. 46 (2000) 139-148
    • (2000) Schizophr. Res. , vol.46 , pp. 139-148
    • Harvey, P.D.1    Moriarty, P.J.2    Serper, M.R.3    Schnur, E.4    Lieber, D.5
  • 6
    • 1642327047 scopus 로고    scopus 로고
    • Randomized, controlled double-blind multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
    • Harvey P.D., Siu C., and Romano S. Randomized, controlled double-blind multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Psychopharmacology 172 (2004) 324-332
    • (2004) Psychopharmacology , vol.172 , pp. 324-332
    • Harvey, P.D.1    Siu, C.2    Romano, S.3
  • 7
    • 11844278220 scopus 로고    scopus 로고
    • Stability of cognitive impairment in elderly schizophrenic patients receiving conventional antipsychotic treatment
    • Harvey P.D., Heaton R.K., Palmer B.A., Mohamed S., Kennedy J., and Brickman A. Stability of cognitive impairment in elderly schizophrenic patients receiving conventional antipsychotic treatment. Am. J. Psychiatry 162 (2005) 110-117
    • (2005) Am. J. Psychiatry , vol.162 , pp. 110-117
    • Harvey, P.D.1    Heaton, R.K.2    Palmer, B.A.3    Mohamed, S.4    Kennedy, J.5    Brickman, A.6
  • 9
    • 34247643916 scopus 로고    scopus 로고
    • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia
    • Keefe R.S., Bilder R.M., Davis S.M., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia. Arch. Gen. Psychiatry 64 (2007) 633-647
    • (2007) Arch. Gen. Psychiatry , vol.64 , pp. 633-647
    • Keefe, R.S.1    Bilder, R.M.2    Davis, S.M.3
  • 11
    • 53149148398 scopus 로고    scopus 로고
    • Sacchetti, E., Galluzzo, A., Valsecchi, P., Romeo, F., Gorini, B., Warrington, L., submitted for publication. Comparative Efficacy and Safety of Ziprasidone and Clozapine in the Treatment of Resistant and/or Intolerant Schizophrenic Patients: Results of a Randomized, Double-Blind, 18-Week Trial.
    • Sacchetti, E., Galluzzo, A., Valsecchi, P., Romeo, F., Gorini, B., Warrington, L., submitted for publication. Comparative Efficacy and Safety of Ziprasidone and Clozapine in the Treatment of Resistant and/or Intolerant Schizophrenic Patients: Results of a Randomized, Double-Blind, 18-Week Trial.
  • 13
    • 21244448316 scopus 로고    scopus 로고
    • A meta-analysis of neuropsychological change to change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
    • Woodward, N.D., Purdon, S.E., Meltzer, H.Y., Zald, and D.H. A meta-analysis of neuropsychological change to change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 8 (2005) 457-472
    • (2005) Int. J. Neuropsychopharmacol. , vol.8 , pp. 457-472
    • Woodward,, N.D.1    Purdon,, S.E.2    Meltzer,, H.Y.3    Zald,, D.H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.